🔗 Share this article

This year's Nobel Prize in Physiology or Medicine has been awarded for transformative findings that illuminate how the body's defense network targets harmful pathogens while sparing the healthy tissues.

Three esteemed researchers—from Japan Prof. Sakaguchi and American experts Dr. Brunkow and Fred Ramsdell—share this honor.

The research uncovered specialized "sentinels" within the defense system that remove rogue immune cells that could attacking the body.

The findings are now paving the way for innovative treatments for autoimmune diseases and cancer.

The laureates will share a monetary award valued at 11m SEK.

Crucial Findings

"The work has been essential for understanding how the body's defenses functions and why we don't all suffer from serious autoimmune diseases," commented the chair of the award panel.

The team's research address a core question: How does the immune system protect us from numerous invaders while leaving our own tissues intact?

Our body's protection system employs immune cells that search for indicators of infection, including viruses and germs it has not met before.

These cells utilize sensors—known as recognition units—that are generated randomly in countless combinations.

This provides the defense network the ability to combat a broad range of threats, but the randomness of the process inevitably creates immune cells that may target the host.

Security Guards of the Immune System

Researchers earlier understood that a portion of these harmful defense cells were destroyed in the immune organ—the site where white blood cells mature.

The latest Nobel Prize recognizes the discovery of regulatory T-cells—described as the immune system's "security guards"—which patrol the body to neutralize other defenders that attack the body's own tissues.

It is known that this process malfunctions in autoimmune diseases such as type-1 diabetes, MS, and RA.

The prize committee stated, "These discoveries have established a new field of investigation and accelerated the development of new treatments, for instance for cancer and immune disorders."

Regarding cancer, T-regs prevent the system from attacking the growth, so studies are focused on lowering their numbers.

In self-attack disorders, experiments are exploring increasing regulatory T-cells so the body is not being harmed. A comparable approach could also be useful in reducing the chances of transplanted organ failure.

Innovative Experiments

Professor Shimon Sakaguchi, from a Japanese institution, conducted tests on rodents that had their immune gland extracted, leading to autoimmune disease.

He showed that injecting immune cells from healthy animals could stop the disease—suggesting there was a mechanism for blocking immune cells from attacking the body.

Mary Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Dr. Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an genetic immune disorder in mice and humans that led to the discovery of a gene critical for how T-regs operate.

"The groundbreaking work has revealed how the body's defenses is controlled by regulatory T cells, stopping it from accidentally attacking the body's own tissues," commented a leading physiology expert.

"This research is a striking example of how basic biological study can have broad consequences for human health."